Table 2 Dosing, dose reductions and sequencing of nal-IRI + 5-FU/LV
N = 56 (%) | |
|---|---|
Starting nal-IRI dose (mg/m2) | |
< 50 | 23 (41) |
55 | 9 (16) |
60 | 7 (13) |
70 | 17 (30) |
Dose reductions (#) | |
0 | 38 (68) |
1 | 15 (27) |
2 | 3 (5) |
Treatment sequencing | |
FOLF (IRIN) OX ← → (nab-P) + Gem → nal-IRI + 5-FU/LV | 26 (46) |
nab-P + Gem → nal-IRI + 5-FU/LV | 25 (45) |
nab-P + Gem → Gem/Cap → nal-IRI + 5-FU/LV | 3 (5) |
other | 2 (4) |